Table 2.
Concomitant medication of the study patients
| Medication | Nonstatin (n=14) | Statin (n=12) | P-value |
|---|---|---|---|
| Hypercholesterolemia | |||
| Fibrate | 1 | 0 | 0.345 |
| Statin (simvastatin:atorvastatin) | 0 | 12 (9:3) | |
| Diabetes | |||
| Oral only:insulin only:combination | 3 (1:0:2) | 2 (2:0:0) | 0.759 |
| Hypertension | |||
| ACE:AT2 | 3 | 4 | 0.495 |
| β-Blocker | 5 | 6 | 0.462 |
| Calcium channel blocker (vascular:cardioselective) | 3 | 2 | 0.759 |
| Diuretic | 2 | 3 | 0.490 |
| Circulation | |||
| Anticoagulation | 0 | 1 | 0.271 |
| Antithrombotic | 6 | 6 | 0.716 |
| Inotropic | 1 | 0 | 0.345 |
| Nitrate | 2 | 2 | 0.867 |
| Central nervous system | |||
| Antidepressive | 0 | 3 | 0.047 |
| Benzodiazepine | 0 | 1 | 0.271 |
| Dementia | 1 | 0 | 0.345 |
| Nonbenzodiazepine hypnotic | 0 | 1 | 0.271 |
| Gastrointestinal tract | |||
| Proton pump inhibitor | 2 | 2 | 0.867 |
| Other hormones and vitamins | |||
| BPH | 1 | 1 | 0.910 |
| Hormonal substitution | 3 | 2 | 0.759 |
| Thyroxin | 1 | 2 | 0.449 |
| Vitamins and micronutrients* | 2 | 3 | 0.490 |
| Immunomodulation | |||
| Antihistamines | 3 | 1 | 0.356 |
| Glucocorticoid | 1 | 0 | 0.345 |
| Glucocorticoid inhalated | 2 | 5 | 0.117 |
| NSAIDs | 0 | 1 | 0.271 |
| Infection | |||
| Antibiotic | 1 | 0 | 0.345 |
| Topical medication | |||
| Allergy | 1 | 0 | 0.345 |
| Glaucoma | 0 | 1 | 0.271 |
Notes: Data presented as N-value of concomitant preoperative medication of 14 eyes of 14 nonstatin and 12 eyes of eleven statin-treated patients. For two-group comparisons, qualitative data were analyzed by two-factor χ2 test.
*
Vitamins and micronutrients counted by prescription. P≤0.05 shows a statistically significant result between the groups.
Abbreviations: ACE, angiotensin converting enzyme inhibitor; AT2, angiotensin II receptor antagonist; BPH, benign prostatic hyperplasia; NSAIDs, nonsteroidal anti-inflammatory drugs.